AST Elevation in Dengue Fever
Primary Mechanism of Hepatocellular Injury
AST elevation in dengue fever results from direct viral infection of hepatocytes combined with immune-mediated cytopathic damage, with the virus binding to hepatocytes through angiotensin-converting enzyme 2 (ACE2) receptors that are highly expressed in liver tissue. 1, 2
The dengue virus causes hepatocellular injury through multiple overlapping mechanisms:
- Direct viral cytotoxicity: Dengue virus directly infects hepatocytes and bile duct epithelial cells via ACE2 receptors, leading to cellular damage and enzyme release 1
- Immune-mediated injury: The inflammatory response generates cytokine-mediated damage, with significantly elevated IL-10 and IL-17 levels correlating with severe dengue and hepatic injury 3
- Hypoxic injury: Decreased hepatic perfusion during plasma leakage and shock states contributes to centrilobular hepatocyte damage 3
Characteristic Pattern of Enzyme Elevation
AST rises disproportionately higher than ALT in dengue fever, with AST levels typically 2-3 times greater than ALT—a pattern opposite to most other viral hepatitides. 4, 5
The temporal pattern shows:
- Peak elevation occurs on days 6-7 of illness, approximately 24 hours after peak viremia and 24 hours before maximum plasma leakage 3
- AST levels in dengue fever average 84.5±42.4 IU/L, while in dengue hemorrhagic fever they reach 507±106.8 IU/L 4
- ALT levels are consistently lower: 59.9±31.3 IU/L in dengue fever versus 234±30.6 IU/L in dengue hemorrhagic fever 4
- Transaminases typically normalize within 2 weeks of symptom onset 5
Zonal Pattern of Liver Damage
Dengue-induced hepatocellular damage initiates predominantly in the centrilobular zone and progresses toward the periportal area as disease severity increases. 2
This is demonstrated by:
- Centrilobular enzymes (GLDH, αGST) show marked elevation correlating with AST levels 2
- Periportal enzymes (ARG-1, HPPD) become elevated as disease progresses to severe dengue 2
- The pattern suggests initial hypoxic injury in zone 3 (centrilobular) followed by direct viral and immune-mediated damage extending to zone 1 (periportal) 2, 3
Correlation with Disease Severity
Higher AST levels serve as an early indicator of dengue severity, with levels >400 IU/L significantly associated with dengue hemorrhagic fever and severe dengue. 4, 6
However, important caveats exist:
- While median AST values increase with severity, there is substantial overlap between dengue fever and dengue hemorrhagic fever groups 6
- AST poorly discriminates between non-severe and severe dengue (area under ROC curve = 0.62) 6
- AST ≥1000 IU/L occurs in only a small subset of patients but indicates severe dengue by WHO 2009 criteria 6
- Severe hepatic injury can occur without plasma leakage or hemoconcentration, suggesting immune mechanisms independent of vascular permeability 3
Clinical Significance and Outcomes
Despite marked transaminase elevations (93.3% of patients have elevated AST), acute liver failure is rare in dengue fever, and most patients recover without specific hepatic intervention. 5, 6
Critical points for management:
- Hepatic failure accounts for approximately 60% of dengue-related deaths when it occurs (3 of 5 fatal cases in one series) 5
- Transaminase elevation >10-fold above normal occurs in 11.1% for AST and 7.4% for ALT 5
- Significantly higher AST, ALT, and GGT elevations occur in patients with bleeding episodes 5
- Liver biopsy when performed shows features of lobular hepatitis similar to conventional viral hepatitis 5
Why AST Exceeds ALT
The AST:ALT ratio >1 in dengue fever likely reflects the combination of hepatocellular injury plus AST release from other damaged tissues including endothelial cells, platelets, and cardiac muscle during the systemic inflammatory response. 4, 5
This differs from typical viral hepatitis where ALT predominates because:
- AST is present in mitochondria and cytoplasm of hepatocytes, while ALT is primarily cytoplasmic 7
- Dengue causes more severe mitochondrial damage, releasing mitochondrial AST 2
- Systemic endothelial activation and platelet destruction contribute additional AST from non-hepatic sources 3
- The centrilobular predominance of initial injury affects hepatocytes with higher mitochondrial content 2